ABBLO PHARMA ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About ABBLO PHARMA ApS
ABBLO PHARMA ApS (CVR number: 34080534) is a company from GENTOFTE. The company recorded a gross profit of 806.1 kDKK in 2023. The operating profit was 180.4 kDKK, while net earnings were 107.4 kDKK. The profitability of the company measured by Return on Assets (ROA) was 12.1 %, which can be considered good and Return on Equity (ROE) was 8.1 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at -12.9 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. ABBLO PHARMA ApS's liquidity measured by quick ratio was 1.5 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | 306.37 | 375.63 | 740.46 | 1 056.15 | 806.14 |
EBIT | 151.90 | 252.79 | 315.53 | 357.56 | 180.45 |
Net earnings | 100.47 | 213.83 | 285.24 | 300.77 | 107.38 |
Shareholders equity total | -1 128.26 | - 914.43 | - 629.19 | - 328.42 | - 221.04 |
Balance sheet total (assets) | 516.09 | 764.11 | 882.25 | 1 161.69 | 1 498.67 |
Net debt | 1 155.73 | 806.98 | 747.61 | 711.28 | 259.43 |
Profitability | |||||
EBIT-% | |||||
ROA | 8.9 % | 15.3 % | 21.0 % | 25.1 % | 12.1 % |
ROE | 18.4 % | 33.4 % | 34.7 % | 29.4 % | 8.1 % |
ROI | 10.9 % | 21.8 % | 34.5 % | 40.6 % | 21.5 % |
Economic value added (EVA) | 219.61 | 317.94 | 371.59 | 398.53 | 207.59 |
Solvency | |||||
Equity ratio | -68.6 % | -54.5 % | -41.6 % | -22.0 % | -12.9 % |
Gearing | -117.3 % | -110.3 % | -148.4 % | -281.0 % | -402.3 % |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 1.0 | 0.7 | 0.9 | 1.2 | 1.5 |
Current ratio | 1.6 | 1.1 | 1.5 | 2.0 | 1.8 |
Cash and cash equivalents | 168.19 | 201.19 | 186.26 | 211.70 | 629.75 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BB | BB | BBB | BBB | BB |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.